News from our community and beyond
Every month we provide our subscribers with some of the latest news about our projects and studies and how we are working to ensure that medicines and vaccines are made available for children in the right dose, formulation and at the right time.
Sign up to the Penta Newsletter to keep up to date with us!
Before proceeding, please read our Newsletter Privacy Notice.
Recent issues
February 2026: Explore our research at CROI 2026
At this year’s Conference on Retroviruses and Opportunistic Infections (CROI), Penta once again had a strong presence, with oral presentations and posters highlighting progress from some of our studies. The D3 findings are especially significant for children and adolescents living with HIV. Results show that a two-drug regimen of dolutegravir/lamivudine (DTG/3TC) is just as effective as the standard three-drug approach, with many practical benefits that could improve daily life for children and their caregivers facing lifelong treatment.
January 2026: Join PentaTr@ining, discover our new trial & more January updates
If advancing your expertise and improving care for children, adolescents and pregnant people living with HIV and other congenital infections is part of your 2026 goals, this January we have the perfect opportunity for you. PentaTr@ining’s flagship hybrid course, “HIV & Other Congenital Infections” is about to return for its 2026 edition! Starting in just three months, now is the ideal time to secure your place. Registration is open, and we look forward to welcoming healthcare professionals from all settings to this year’s cohort.
December 2025: Overcoming disruption, transforming the AIDS response (World AIDS Day)
This World AIDS Day, we embrace UNAIDS’s call to overcome disruption and transform the AIDS response. Global health has faced unprecedented challenges like funding cuts, political uncertainty and fragile health systems, that threaten decades of progress against HIV. Yet disruption can also drive innovation. For Penta, this theme is both a challenge and an opportunity: to adapt, strengthen and ensure that our work continues to deliver impact for children and families worldwide.